November 21, 2024- QuidelOrtho Corporation announced the pricing of the previously announced underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (the “Selling Stockholder”) of 8,260,183 shares of the Company’s common stock (“Common Stock”). The Selling Stockholder will receive all of the proceeds from the Offering. The Company is not selling any shares of Common Stock in the Offering and will not receive any proceeds from the Offering.
Goldman Sachs & Co. LLC is acting as the sole underwriter of the Offering. The Offering is expected to close on November 21, 2024, subject to customary closing conditions.
Goldman Sachs & Co. LLC will offer the shares of Common Stock to the public at a fixed price, which may be changed at any time without notice.